Results 141 to 150 of about 7,628 (191)

Dysregulated TFEB-autophagy-lysosome pathway links acute COVID-19 immunopathology to Long COVID sequelae. [PDF]

Front Immunol
Gabig-Cimińska M.
europepmc   +1 more source

Computational modelling of the equine arteritis virus GP5/M Dimer: Implications for immune evasion and virulence. [PDF]

PLoS One
Veit M, Matczuk AK.
europepmc   +1 more source

Editorial: Immunological regulation to enteroviruses and respiratory viruses: infection and vaccination responses. [PDF]

Front Immunol
Zheng H.
europepmc   +1 more source

Convergent hub pathways targeted by IAV, SARS-CoV-2, and RSV in type II alveolar epithelial cells: molecular mechanisms and therapeutic implications. [PDF]

Front Immunol
Zhang K, Zhu S, Zhang M, Hu H, Qin S, Li H, Zhao P, Xu Y.   +7 more
europepmc   +1 more source

SIRT2 suppresses aging-associated cGAS activation and protects aged mice from severe COVID-19. [PDF]

Cell Rep
Barthez M, Xue B, Zheng J, Wang Y, Song Z, Mu WC, Wang CL, Guo J, Yang F, Ma Y, Wei X, Ye C, Sims N, Martinez-Sobrido L, Perlman S, Chen D.   +15 more
europepmc   +1 more source

Targeting SIRT1: A Potential Strategy for Combating Severe COVID-19. [PDF]

Biomed Res Int
Shokri-Afra H, Saber Jeyvan F, Barartabar Z, Khanicheragh P, Yousefi Abdolmaleki E, Ilbeigi D, Musavi H, Malekzadegan Y.   +7 more
europepmc   +1 more source

Examining the feasibility of replacing ORF3a with fluorescent genes to construct SARS-CoV-2 reporter viruses. [PDF]

J Gen Virol
Webb I, Erdmann M, Milligan R, Savage M, Matthews DA, Davidson AD.   +5 more
europepmc   +1 more source

SARS-CoV-2 Nsp1 Is a Major Suppressor of HLA Class I and Class II Expression. [PDF]

Viruses
Schirmeister I, Eckert N, Weigang S, Fuchs J, Kern L, Kochs G, Halenius A.   +6 more
europepmc   +1 more source

A live attenuated SARS-CoV-2 vaccine constructed by dual inactivation of NSP16 and ORF3a. [PDF]

EBioMedicine
Ye ZW, Ong CP, Cao H, Tang K, Gray VS, Hinson Cheung PH, Wang J, Li W, Zhang H, Luo P, Ni T, Chan CP, Zhang M, Zhang Y, Ling GS, Yuan S, Jin DY.   +16 more
europepmc   +1 more source

New Circulating Variants of SARS-CoV-2 in Asturias During the Period (2022-2024). [PDF]

Viruses
González-Alba JM, Martínez ZP, Rojo-Alba S, Varela CO, Oña JG, Pérez MR, García SM, Álvarez-Argüelles ME.   +7 more
europepmc   +1 more source